Hepatitis B is a vaccine-preventable viral disease that involves inflammation of the liver. The hepatitis B virus (HBV) usually leads to a short-term infection known as acute hepatitis B.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Hepatitis B vaccine (recombinant) 10mcg/0.5mL, 20mcg/mL; susp; aluminum hydroxide adsorbed; IM inj; preservative-free. Infection with hepatitis B virus can have serious consequences including ...

Vaccination against HBV began 30 years ago with availability of plasma-derived, inactivated HBsAg vaccines. Soon after, recombinant ... implementation of universal hepatitis vaccination in most ...

In Hepatitis B: The Hunt for a Killer Virus ... in protecting against HBV infection. Although recombinant antigen is used in most vaccines today, the initial proof of principle with a vaccine ...

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Methods: We determined antibody to hepatitis B surface antigen (anti-HBs ... In low risk children initially receiving a recombinant vaccine, 12.5% (26 of 208) and none (0 of 36) retained ...

Hepatitis B surface antigen vaccine (recombinant) 5mcg/0.5mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free. Ped/Adolescent 5mcg/0.5mL: single-dose vials (yellow cap), single ...

Interferon Alfa-2B Recombinant, 10 million IU National Museum of American History Recombivax HB, Hepatitis B Vaccine (Recombinant) Pediatric Formulation, 0.5 mL National Museum of American History ...

A new study conducted during the first-ever reactive use of the Hecolin vaccine in South Sudan showed that a two-dose regimen ...